Exelixis Inc (NAS:EXEL)
$ 35.92 0.07 (0.2%) Market Cap: 10.26 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.03 PB Ratio: 4.51 GF Score: 91/100

Exelixis Inc at Cowen HealthCare Conference Transcript

Mar 03, 2020 / 03:00PM GMT
Release Date Price: $18.74 (-2.85%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. Well, welcome once again to the 40th Annual Health Care Conference at Cowen. I'm Yaron Werber, biotech analyst here on the team. And it's a great pleasure to moderate the fireside chat with Mike Morrissey, who is the President and Chief Executive Officer at Exelixis. So Mike, thanks so much for joining.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Great to be here. Thank you.

Questions & Answers

Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Maybe the first question to you is, how many years has it been now for you at Exelixis?

Michael M. Morrissey;Yaron
Exelixis, Inc. - CEO, President & Director

Wow, I just celebrated my 20th anniversary on February 3. So it's like 10 biotech half-lives. So happy I made it so far. So a lot more time to go, for sure.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot